199 related articles for article (PubMed ID: 12491208)
1. Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment.
Fleming CA; Craven DE; Thornton D; Tumilty S; Nunes D
Clin Infect Dis; 2003 Jan; 36(1):97-100. PubMed ID: 12491208
[TBL] [Abstract][Full Text] [Related]
2. Therapy of hepatitis C in HIV-coinfection.
Rockstroh JK; Vogel M
Eur J Med Res; 2004 Jun; 9(6):304-8. PubMed ID: 15257871
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hepatitis C virus/HIV coinfection.
Chun S; Sherman KE
Clin Liver Dis; 2005 Aug; 9(3):525-33, ix. PubMed ID: 16023981
[TBL] [Abstract][Full Text] [Related]
4. Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life.
Cacoub P; Rosenthal E; Halfon P; Sene D; Perronne C; Pol S
J Viral Hepat; 2006 Oct; 13(10):678-82. PubMed ID: 16970599
[TBL] [Abstract][Full Text] [Related]
5. Update on hepatitis C treatment in HIV-coinfected patients.
Camino N; Sheldon J; Soriano V
Minerva Gastroenterol Dietol; 2004 Mar; 50(1):67-77. PubMed ID: 15719008
[TBL] [Abstract][Full Text] [Related]
6. Challenges in the treatment of patients coinfected with HIV and hepatitis C virus: need for team care.
Fleming CA; Tumilty S; Murray JE; Nunes D
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S349-54. PubMed ID: 15768347
[TBL] [Abstract][Full Text] [Related]
7. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
8. Interferon-ribavirin in association with stavudine has no impact on plasma human immunodeficiency virus (HIV) type 1 level in patients coinfected with HIV and hepatitis C virus: a CORIST-ANRS HC1 trial.
Salmon-Céron D; Lassalle R; Pruvost A; Benech H; Bouvier-Alias M; Payan C; Goujard C; Bonnet E; Zoulim F; Morlat P; Sogni P; Pérusat S; Tréluyer JM; Chêne G;
Clin Infect Dis; 2003 May; 36(10):1295-304. PubMed ID: 12746776
[TBL] [Abstract][Full Text] [Related]
9. HIV and hepatitis C virus coinfection: bad bedfellows.
Schooley RT
Top HIV Med; 2005; 13(4):112-6. PubMed ID: 16304454
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C Virus in the HIV-infected patient.
Andersson K; Chung RT
Clin Liver Dis; 2006 May; 10(2):303-20, viii. PubMed ID: 16971263
[TBL] [Abstract][Full Text] [Related]
11. Impact of human immunodeficiency virus infection in patients infected with the hepatitis C virus.
Valle Tovo C; Alves de Mattos A; Ribeiro de Souza A; Ferrari de Oliveira Rigo J; Lerias de Almeida PR; Galperim B; Riegel Santos B
Liver Int; 2007 Feb; 27(1):40-6. PubMed ID: 17241379
[TBL] [Abstract][Full Text] [Related]
12. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management.
Verucchi G; Calza L; Manfredi R; Chiodo F
Infection; 2004 Feb; 32(1):33-46. PubMed ID: 15007741
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
[TBL] [Abstract][Full Text] [Related]
15. Testing, referral, and treatment patterns for hepatitis C virus coinfection in a cohort of veterans with human immunodeficiency virus infection.
Fultz SL; Justice AC; Butt AA; Rabeneck L; Weissman S; Rodriguez-Barradas M;
Clin Infect Dis; 2003 Apr; 36(8):1039-46. PubMed ID: 12684917
[TBL] [Abstract][Full Text] [Related]
16. Should treatment of hepatitis C in HIV-seropositive and HIV-seronegative patients with hemophilia include induction doses of interferon?
McGovern B; Bica I
Clin Infect Dis; 2003 Aug; 37(3):463-4; author reply 464-5. PubMed ID: 12884180
[No Abstract] [Full Text] [Related]
17. Side effects. Safety and effectiveness of interferon and ribavirin in HIV+ people co-infected with hepatitis C virus.
TreatmentUpdate; 2001; 12(8):4-5. PubMed ID: 12132439
[No Abstract] [Full Text] [Related]
18. HIV and hepatitis C coinfection.
Matthews GV; Dore GJ
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
[TBL] [Abstract][Full Text] [Related]
19. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype.
Schwarze-Zander C; Blackard JT; Zheng H; Addo MM; Lin W; Robbins GK; Sherman KE; Zdunek D; Hess G; Chung RT;
J Infect Dis; 2006 Aug; 194(4):410-9. PubMed ID: 16845623
[TBL] [Abstract][Full Text] [Related]
20. Antiviral treatment for hepatitis C virus infection: effectiveness at general population level in a highly endemic area.
Mariano A; Caserta C; Pendino GM; Vacalebre C; Surace P; Fiorillo MT; Polito I; Surace M; Alicante S; Amante A; Foti G; Marra M; Gutamo G; Amato F; Messineo A; Mele A
Dig Liver Dis; 2009 Jul; 41(7):509-15. PubMed ID: 19196557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
